Wendy M Smith Selected Research

Wendy M Smith Research Topics

5	Uveitis 10/2022 - 09/2012
3	Inflammation (Inflammations) 01/2019 - 06/2012
2	Panuveitis 10/2022 - 01/2014
2	Histoplasmosis 07/2022 - 01/2019
2	Cataract (Cataracts) 01/2021 - 01/2018
2	Macular Edema 01/2021 - 09/2012
1	Whipple Disease (Whipple's Disease) 11/2023
1	Iritis 09/2023
1	Lymphoma (Lymphomas) 09/2023
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2023
1	Endophthalmitis (Ophthalmia) 11/2022
1	Disease Progression 10/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 10/2022
1	Choroidal Neovascularization 07/2022
1	Retinal Diseases 06/2021
1	Optic Neuritis (Retrobulbar Neuritis) 01/2020
1	Scleritis (Episcleritis) 01/2018
1	Hemorrhage 01/2018
1	Tuberculosis (Tuberculoses) 08/2016
1	Osteonecrosis (Kienbock's Disease) 04/2013
1	Raynaud Disease (Raynaud's Disease) 04/2013
1	Sickle Cell Trait 04/2013
1	Thalassemia 04/2013
1	Mycoses (Diseases, Fungus) 02/2013
1	Vasculitis (Vasculitides) 09/2012
1	Retinal Vasculitis 09/2012
1	Infections 09/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2012
1	Anterior Uveitis 06/2012
1	Anosmia 07/2010
1	Insulin Resistance 10/2002
1	Carcinogenesis 10/2002
1	Colonic Neoplasms (Colon Cancer) 10/2002
1	Type 2 Diabetes Mellitus (MODY) 10/2002
1	Neoplasms (Cancer) 10/2002
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2002
1	Glomus Tumor (Glomus Tumors) 05/2002
1	Pheochromocytoma 05/2002
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 05/2002

3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 09/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 01/2018
2	prednisolone acetate FDA LinkGeneric 09/2023 - 02/2013
1	Periodic AcidIBA 11/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 11/2023
1	Methotrexate (Mexate)FDA LinkGeneric 09/2023
1	Interleukin-10 (Interleukin 10)IBA 09/2023
1	Endothelial Growth FactorsIBA 11/2022
1	encorafenibIBA 10/2022
1	VemurafenibIBA 10/2022
1	dabrafenibIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	SteroidsIBA 08/2016
1	Viral DNAIBA 01/2014
1	AutoantibodiesIBA 04/2013
1	Voriconazole (Vfend)FDA LinkGeneric 02/2013
1	Ophthalmic Solutions (Eye Drops)IBA 02/2013
1	Rifabutin (Ansamycin)FDA Link 09/2012
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2012
1	Sirolimus (Rapamycin)FDA Link 06/2012
1	ZincIBA 07/2010
1	gluconic acid (gluconate)FDA LinkGeneric 07/2010
1	AzoxymethaneIBA 10/2002
1	PPAR gammaIBA 10/2002
1	beta CateninIBA 10/2002
1	LigandsIBA 10/2002
1	ThiazolidinedionesIBA 10/2002
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2002

4	Therapeutics 10/2022 - 10/2002
3	Injections 11/2022 - 01/2018
1	Perioperative Period 01/2021
1	Immunomodulation 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 02/2013